Reliance BioGas

Sector: Renewable Energy (Compressed Bio-Gas (CBG) Plant)  |  HQ: India  |  Founded: Not separately disclosed  |  Employees: Not separately disclosed

Listed as: Privately held  | 

Company overview

Reliance BioGas operates in the renewable energy segment of the Indian market, with a presence noted in the compressed bio-gas (cbg) plant category. The company is among the recognised participants in this segment alongside other Indian and multinational players. Operations follow the standard Companies Act 2013 disclosure framework where Reliance BioGas is incorporated as a private or public limited company under Indian law, with statutory audit, GST registration under the CGST Act 2017, and applicable sectoral compliance under FSSAI, BIS, MoEF, or sectoral regulators as relevant to the activity. The competitive set in compressed bio-gas (cbg) plant includes pan-India brands, regional players, and multinational subsidiaries operating in India through wholly-owned or joint-venture structures.

Recent developments

May 2026

Reliance BioGas is advancing its compressed bio-gas (CBG) infrastructure with notable plant development activity in southern India. A bhoomi puja ceremony for a Reliance biogas plant in Andhra Pradesh was held in late March 2025, with formal opening by Lokesh scheduled for April 2, 2025 [3, 5]. At the group level, Reliance is positioning biogas as a strategic pillar within its broader green energy transition, with reports noting the hydrocarbon conglomerate is betting on the sector [4]. Analysis suggests this push could help address agricultural stubble-burning, a persistent air quality challenge in northern India [6]. In Gujarat, household-scale biogas adoption is gaining traction, with over 665 homes now operational and more than 1,000 families moving toward energy self-reliance [1, 2].

The narrative reflects two distinct tracks: Reliance's utility-scale CBG plant development anchored in Andhra Pradesh, and the broader ecosystem of community biogas adoption in Gujarat that demonstrates viable demand for bio-gas at the household level. The timing of the Andhra plant opening in April 2025 and ongoing household deployment in Gujarat through mid-2026 suggest parallel momentum across residential and industrial segments.

Sources (6)

1. Gujarat: Over 1,000 families move towards self-reliance, biogas plants operational in 665 homes - Punjab Kesari English · Punjab Kesari English · Fri, 15 May 2026
2. Gujarat: Over 1,000 families move towards self-reliance, biogas plants operational in 665 homes - thehawk.in · thehawk.in · Fri, 15 May 2026
3. Bhoomi puja for Reliance biogas plant in Andhra set for April 2 - The New Indian Express · The New Indian Express · Thu, 27 Mar 2025
4. Why Ambani the hydrocarbon king is betting on a humble business - The Economic Times · The Economic Times · Tue, 12 Nov 2024
5. Lokesh to open Reliance biogas plant tomorrow - The Hans India · The Hans India · Tue, 01 Apr 2025
6. Ambani's quest for green energy can solve stubble-burning problem - The Economic Times · The Economic Times · Mon, 26 Feb 2024

Financial performance and recent trajectory

Disclosed revenue (FY25): Not separately disclosed in segment-wise FY 2024-25 reporting.

Competitive position

Reliance BioGas occupies a position in the compressed bio-gas (cbg) plant category alongside other listed and unlisted Indian players. Competitive intensity in the segment is shaped by raw material cost cycles, distribution depth, branded versus unbranded share, and the regulatory framework governing manufacturing, FSSAI labelling (for food), BIS standards (for engineering goods), or sectoral norms. The principal competitive moats in this category are typically scale, distribution reach, brand trust, and integrated procurement. KAMRIT's project report on compressed bio-gas (cbg) plant benchmarks new entrant economics against the listed peer cost structure including capex per tonne (or per unit of output), working capital intensity, gross margin band, and the EBITDA delta between organised and unorganised participants.

Key risks

Input cost volatility in the compressed bio-gas (cbg) plant value chain Competitive intensity from larger Indian groups and multinational subsidiaries Regulatory tightening under FSSAI, BIS, environmental norms, or labour codes

Outlook

Reliance BioGas is a participant in the Indian compressed bio-gas (cbg) plant category, which forms part of the broader Renewable Energy space. The Indian compressed bio-gas (cbg) plant market continues to evolve with rising organised share, premiumisation, distribution expansion, and a regulatory architecture covering the Companies Act 2013, the Income Tax Act 1961, the CGST Act 2017, the Legal Metrology Act 2009, and sectoral statutes including the Food Safety and Standards Act 2006 (for food and beverage subsegments), the Drugs and Cosmetics Act 1940 (for pharmaceutical or healthcare adjacencies), the Environment Protection Act 1986 (for emissions and effluents), and labour codes consolidated under the four 2020 labour codes. In KAMRIT's project report framework for this category, the competitive set typically includes pan-India branded leaders, multinational subsidiaries, mid-sized regional players, and a long tail of MSME participants. The structural attractiveness of the category for new entrants is a function of (a) market growth rate, (b) the share that remains with unorganised or fragmented operators, (c) the cost of regulatory compliance, and (d) the capex intensity of plant and machinery. The KAMRIT bankable DPR for this category structures a new entrant's economics against this competitive landscape. For Reliance BioGas specifically, public-domain disclosures provide a baseline view of operations, but segment-wise revenue, EBITDA, capacity utilisation, and forward capex plans are not separately broken out in many cases. Where the company is part of a listed group, the SEBI LODR and the Companies Act 2013 governance framework apply, with statutory audit conducted under SA 700 and CARO 2020 reporting. Where the company is unlisted, the Companies Act 2013 framework continues to govern with reduced public disclosure. The risk and opportunity outlook for Reliance BioGas mirrors the broader compressed bio-gas (cbg) plant category dynamics. Demand-side drivers include rising household consumption, urbanisation, organised retail expansion, and policy support including PLI schemes (where applicable to the segment). Supply-side risks include input cost volatility, regulatory tightening, environmental compliance escalation, and competitive intensity from larger groups or imports. Management quality, balance sheet strength, distribution depth, and the capex execution track record are the differentiators within the peer set. KAMRIT's research desk maintains a baseline reference for Reliance BioGas as a peer benchmark within the compressed bio-gas (cbg) plant category. For investors, lenders, or new entrant promoters seeking a fuller assessment of Reliance BioGas, KAMRIT's deep-dive company profile engagement covers financial trajectory, capacity and capex, distribution and customer concentration, regulatory exposure, and the competitive position with named peers.

KAMRIT point of view

Building or competing with Reliance?

KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the renewable energy (compressed bio-gas (cbg) plant) sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of Reliance and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.

View all 1 related project report → Book a scoping call

Related KAMRIT project reports

These reports use Reliance BioGas in benchmarking and competitive analysis sections.

Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.